Furthermore, by functioning as loss-of-function mutations, they may increase the level of Cav-1 phosphorylation, thereby disrupting the normal RNF213 control of NO bioavailability and contributing to changes in vascular tone and the development of arterial stenosis and ischemic events found in MMD patients. This evidence concerns the gene RNF213 and multiminicore myopathy.